Wednesday 4 July 2018, 16.45-17.45
What otolaryngologists must know about human papillomavirus
Nitin Pagedar, University of Iowa
A. Overall objectives:
Human papillomavirus (HPV) has rocked the foundations of head and neck cancer practice over the past decade, impacting epidemiology, treatment decisions, outcomes, and prevention strategies. As science evolves on many parallel fronts, it can be difficult for clinicians to maintain a grasp of both the settled issues as well as the cutting edge. This course will review the basic and applied science of HPV most useful to practicing clinicians.
B. Outline of the session:
We will follow an interactive lecture format with time for questions from attendees.
C. Learning outcomes:
After attending this session, participants will be able to: 1) describe the clinical differences between HPV-positive and –negative oropharynx cancer; 2) understand the clinical tests currently in use for HPV in oropharynx cancer; 3) describe implications of HPV trends for treatment selection and primary prevention.
D. Who the session is aimed at:
This session is appropriate for any otolaryngologist, otolaryngology trainee, or other clinician involved in the care of head and neck cancer patients.